Announcement

Collapse
No announcement yet.

Cureus . Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cureus . Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?


    Cureus


    . 2021 Nov 26;13(11):e19919.
    doi: 10.7759/cureus.19919. eCollection 2021 Nov.
    Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?


    Mani Maheshwari 1 , Hemanthkumar Athiraman 1



    Affiliations

    Abstract

    Remdesivir is an antiviral that inhibits RNA-dependent RNA polymerases of coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a cornerstone of therapy for hospitalized patients with coronavirus disease 2019 (COVID-19), especially those worsening from a respiratory standpoint despite being started on antibiotics, dexamethasone, zinc, and vitamin C. This is a case report describing two COVID-19-positive patients with bradycardia after starting remdesivir. Once remdesivir was discontinued, one patient corrected to normal sinus rhythm, and the other continued with persistent bradycardia.

    Keywords: adult hospital medicine; arrythymia; covid-19; drug induced bradycardia; remdesivir.

Working...
X